← Back to Patent Explorer
US5045565A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain

Assignee: Procter and Gamble Co
•
Filing: 1989-09-08
•
Granted: 1991-09-03
•
Expires: 2009-09-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to beta-aminoethyl-substituted phenyl compounds, especially beta-aminoethoxy-substituted phenyl compounds. The present invention also relates to pharmaceutical compositions comprising a safe and effective amount of a compound of the present invention and a pharmaceutically-acceptable carrier. The present invention further relates to methods for producing analgesia and reducing inflammation, in humans and lower animals, by administering the compounds or compositions of the present invention. In addition, the present invention relates to methods for making compounds of the present invention and intermediates useful in these synthesis methods.

Inventors

  • 👤 Joseph H. Gardner
  • 👤 Gerald B. Kasting
  • 👤 Thomas L. Cupps
  • 👤 Richard S. Echler
  • 👤 Thomas W. Gibson
  • 👤 Joel I. Shulman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 18:33
CPC Classifications
C; C07; C07C; C07C335/00; C07C335/04; C07C335/06; C07C335/10; C07C335/12

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 303 words
Beta-aminoethyl-substituted phenyl compounds which are effective as anti-inflammatory or analgesic agents, and the pharmaceutically-acceptable salts and amides thereof, having the general structure: ##STR45## wherein: (a) the --W--X-- moiety is selected from the group consisting of --C(O)NH--, --C(S)NH--, --S(O) 2 NH--, --NHC(O)O--, --NHC(S)O--, --NHC(O)NH-- and --NHC(S)NH-- wherein either available bond of the --W--X-- moiety is bonded to the --R moiety and the remaining bond is attached to the benzyl carbon atom; (b) --Y-- is a moiety selected from the group consisting of --O--, --S-- and --NR 4 --, where --R 4 is selected from hydrogen and C 1 -C 4 alkanyl; (c) --Z is selected from the group consisting of hydrogen, hydroxy, and methoxy; (d) --R is an alkyl group having from about 1 to about 24 carbon atoms; (e) --R 1 is selected from the group consisting of hydrogen, hydroxy, alkyl esters of hydroxy having from about 1 to about 5 carbon atoms, alkyl having from about 1 to about 5 carbon atoms, and alkoxy having from about 1 to about 5 carbon atoms; and (f) each --R 2 is independently selected from hydrogen, halogen, unsubstituted or substituted alkyl having from about 1 to about 6 carbon atoms, substituted or unsubstituted aryl, and carboxylate, or two --R 2 moieties are covalently bonded to form a substituted or unsubstituted alkyl or aryl ring having from about 3 to about 8 carbon atoms in the ring; wherein any alkyl ring substituent is selected from the group consisting of halogen, hydroxy, amino, aryl, carboxylate, and --OR 3 wherein --R 3 is unsubstituted alkyl having from about 1 to about 3 carbon atoms; and wherein any aryl substituent is selected from the group consisting of halogen, hydroxy, C 1 -C 16 alkoxy, amino, nitro, cyano, phenyl, benzyl, benzyloxy, trifluoromethyl, formylamino, carboxylate and C 1 -C 6 alkyl.
Claim 2
Dependent Claim 303 words
Beta-aminoethyl-substituted phenyl compounds which are effective as anti-inflammatory or analgesic agents, and the pharmaceutically-acceptable salts and amides thereof, having the general structure: ##STR45## wherein: (a) the --W--X-- moiety is selected from the group consisting of --C(O)NH--, --C(S)NH--, --S(O) 2 NH--, --NHC(O)O--, --NHC(S)O--, --NHC(O)NH-- and --NHC(S)NH-- wherein either available bond of the --W--X-- moiety is bonded to the --R moiety and the remaining bond is attached to the benzyl carbon atom; (b) --Y-- is a moiety selected from the group consisting of --O--, --S-- and --NR 4 --, where --R 4 is selected from hydrogen and C 1 -C 4 alkanyl; (c) --Z is selected from the group consisting of hydrogen, hydroxy, and methoxy; (d) --R is an alkyl group having from about 1 to about 24 carbon atoms; (e) --R 1 is selected from the group consisting of hydrogen, hydroxy, alkyl esters of hydroxy having from about 1 to about 5 carbon atoms, alkyl having from about 1 to about 5 carbon atoms, and alkoxy having from about 1 to about 5 carbon atoms; and (f) each --R 2 is independently selected from hydrogen, halogen, unsubstituted or substituted alkyl having from about 1 to about 6 carbon atoms, substituted or unsubstituted aryl, and carboxylate, or two --R 2 moieties are covalently bonded to form a substituted or unsubstituted alkyl or aryl ring having from about 3 to about 8 carbon atoms in the ring; wherein any alkyl ring substituent is selected from the group consisting of halogen, hydroxy, amino, aryl, carboxylate, and --OR 3 wherein --R 3 is unsubstituted alkyl having from about 1 to about 3 carbon atoms; and wherein any aryl substituent is selected from the group consisting of halogen, hydroxy, C 1 -C 16 alkoxy, amino, nitro, cyano, phenyl, benzyl, benzyloxy, trifluoromethyl, formylamino, carboxylate and C 1 -C 6 alkyl.
Claim 3
Dependent Claim 32 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 1, wherein --Y-- is --O--, and --R 1 is selected from the group consisting of hydrogen, hydroxy, and methyl.
Claim 4
Dependent Claim 87 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceuticlly-acceptable salts and amides thereof, according to claim 2, wherein --R 1 is hydrogen; both --R 2 on the alpha carbon atom are hydrogen; both --R 2 on the beta carbon atom are selected from hydrogen and alkyl having from 1 to about 5 carbon atoms or the --R 2 are covalently bonded to form an alkyl ring having from about 3 to about 6 carbon atoms, the alkyl or alkyl ring being unsubstituted or substituted with phenyl; and --Z is methoxy.
Claim 5
Dependent Claim 269 words
Beta-aminoethyl-substituted phenyl compounds which are effective as anti-inflammatory or analgesic agents, and the pharmaceutically-acceptable salts and amides thereof, having the general structure: ##STR46## wherein: (a) ═Q is selected from the group consisting of oxygen or sulfur; (b) --Y-- is a moiety selected from the group consisting of --O--, --S-- and --NR 4 --, where --R 4 is selected from hydrogen and C 1 -C 4 alkanyl; (c) --Z is selected from the group consisting of hydrogen, hydroxy, and methoxy; (d) --R is an alkyl group having from about 1 to about 24 carbon atoms; (e) --R 1 is selected from the group consisting of hydrogen, hydroxy, alkyl esters of hydroxy having from about 1 to about 5 carbon atoms, alkyl having from about 1 to about 5 carbon atoms, and alkoxy having from about 1 to about 5 carbon atoms; and (f) each --R 2 is independently selected from hydrogen, halogen, unsubstituted or substituted alkyl having from about 1 to about 6 carbon atoms, substituted or unsubstituted aryl, and carboxylate, or two --R 2 moieties are covalently bonded to form a substituted or unsubstituted alkyl or aryl ring having from about 3 to about 8 carbon atoms in the ring; wherein any alkyl ring substituent is selected from the group consisting of halogen, hydroxy, amino, aryl, carboxylate, and --OR 3 wherein --R 3 is unsubstituted alkyl having from about 1 to about 3 carbon atoms; and wherein any aryl substituent is selected from the group consisting of halogen, hydroxy, C 1 -C 16 alkoxy, amino, nitro, cyano, phenyl, benzyl, benzyloxy, trifluoromethyl, formylamino, carboxylate and C 1 -C 6 alkyl.
Claim 6
Dependent Claim 269 words
Beta-aminoethyl-substituted phenyl compounds which are effective as anti-inflammatory or analgesic agents, and the pharmaceutically-acceptable salts and amides thereof, having the general structure: ##STR46## wherein: (a) ═Q is selected from the group consisting of oxygen or sulfur; (b) --Y-- is a moiety selected from the group consisting of --O--, --S-- and --NR 4 --, where --R 4 is selected from hydrogen and C 1 -C 4 alkanyl; (c) --Z is selected from the group consisting of hydrogen, hydroxy, and methoxy; (d) --R is an alkyl group having from about 1 to about 24 carbon atoms; (e) --R 1 is selected from the group consisting of hydrogen, hydroxy, alkyl esters of hydroxy having from about 1 to about 5 carbon atoms, alkyl having from about 1 to about 5 carbon atoms, and alkoxy having from about 1 to about 5 carbon atoms; and (f) each --R 2 is independently selected from hydrogen, halogen, unsubstituted or substituted alkyl having from about 1 to about 6 carbon atoms, substituted or unsubstituted aryl, and carboxylate, or two --R 2 moieties are covalently bonded to form a substituted or unsubstituted alkyl or aryl ring having from about 3 to about 8 carbon atoms in the ring; wherein any alkyl ring substituent is selected from the group consisting of halogen, hydroxy, amino, aryl, carboxylate, and --OR 3 wherein --R 3 is unsubstituted alkyl having from about 1 to about 3 carbon atoms; and wherein any aryl substituent is selected from the group consisting of halogen, hydroxy, C 1 -C 16 alkoxy, amino, nitro, cyano, phenyl, benzyl, benzyloxy, trifluoromethyl, formylamino, carboxylate and C 1 -C 6 alkyl.
Claim 7
Dependent Claim 32 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 4, wherein --Y-- is --O--, and --R 1 is selected from the group consisting of hydrogen, hydroxy and methyl.
Claim 8
Dependent Claim 18 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 5, wherein ═Q is oxygen.
Claim 9
Dependent Claim 126 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 6, wherein --R 1 is hydrogen; both --R 2 on the alpha carbon atom are hydrogen; both --R 2 on the beta carbon atom are selected from hydrogen and alkyl having from 1 to about 5 carbon atoms or the --R 2 are covalently bonded to form an alkyl ring having from about 3 to about 6 carbon atoms, the alkyl or alkyl ring being unsubstituted or substituted with phenyl; and --R is selected from the group consisting of alkanyl groups having from about 6 to about 14 carbon atoms, alkenyl groups having from about 14 to about 22 carbon atoms, and alkynyl groups having from about 14 to about 22 carbon atoms.
Claim 10
Dependent Claim 55 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 7, wherein --Z is methoxy; and --R is selected from the group consisting of n-hexanyl, n-heptanyl, n-octanyl, n-nonanyl, n-decanyl, n-undecanyl, n-dodecanyl, n-tridecanyl, n-tetradecanyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, nonadecenyl, eicosenyl, docosenyl, octadecadienyl, nonadecadienyl, eicosadienyl, octadecatrienyl, eicosatrienyl, eicosatetraenyl, octadecynyl, nonadecynyl, eicosynyl, and docosynyl.
Claim 11
Dependent Claim 110 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 8, wherein both --R 2 on the beta carbon atom are selected from the group consisting of hydrogen, methyl, ethyl, and both --R 2 being covalently bonded to form a C 3 -C 5 saturated alkyl ring; and --R is selected from the group consisting of n-octanyl; n-nonanyl; n-decanyl; 9E- or 9Z-tetradecenyl; 9E- or 9Z-hexadecenyl; 9E- or 9Z-octadecenyl; 6E- or 6Z-octadecenyl; 11E- or 11Z-octadecenyl; 10E- or 10Z-nonadecenyl; 13E- or 13Z- docosenyl; 9-methylene-1-octadecanyl; 9Z,12Z-octadecadienyl; 9E, 12E-octadecadienyl; 9Z, 12E-octadecadienyl; 9Z, 11E-octadecadienyl; 10E, 13E-nonadecadienyl; 11E,14E-eicosadienyl; 9Z, 12Z, 15Z-octadecatrienyl; 6Z, 9Z, 12Z-octadecatrienyl; 11Z, 14Z, 17Z-eicosatrienyl; 5Z, 8Z, 11Z, 14Z-eicosatetraenyl; and 9-octadecynyl.
Claim 12
Dependent Claim 25 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 9, selected from the group consisting of N-(9Z-octadecenyl)-4-(2-aminoethoxy)-3-methoxyphenylacetamide, N-octanyl-4(2-aminoethoxy)-3-methoxyphenylacetamide, N-(9Z-octadecenyl)-4-(2-amino-2-methylpropoxy)-3-methoxyphenylacetamide, and N-octanyl-4-(2-amino-2-methylpropoxy)-3-methoxyphenylacetamide.
Claim 13
Dependent Claim 36 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 7, where both --R 2 on the alpha carbon atoms are hydrogen and both --R 2 on the beta carbon atom are methyl.
Claim 14
Dependent Claim 20 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 7, where all --R 2 are hydrogen.
Claim 15
Dependent Claim 269 words
Beta-aminoethyl-substituted phenyl compounds which are effective as anti-inflammatory or analgesic agents, and the pharmaceutically-acceptable salts and amides thereof, having the general structure: ##STR47## wherein: (a) ═Q is selected from the group consisting of oxygen or sulfur; (b) --Y-- is a moiety selected from the group consisting of --O--, --S-- and --NR 4 --, where --R 4 is selected from hydrogen and C 1 -C 4 alkanyl; (c) --Z is selected from the group consisting of hydrogen, hydroxy, and methoxy; (d) --R is an alkyl group having from about 1 to about 24 carbon atoms; (e) --R 1 is selected from the group consisting of hydrogen, hydroxy, alkyl esters of hydroxy having from about 1 to about 5 carbon atoms, alkyl having from about 1 to about 5 carbon atoms, and alkoxy having from about 1 to about 5 carbon atoms; and (f) each --R 2 is independently selected from hydrogen, halogen, unsubstituted or substituted alkyl having from about 1 to about 6 carbon atoms, substituted or unsubstituted aryl, and carboxylate, or two --R 2 moieties are covalently bonded to form a substituted or unsubstituted alkyl or aryl ring having from about 3 to about 8 carbon atoms in the ring; wherein any alkyl ring substituent is selected from the group consisting of halogen, hydroxy, amino, aryl, carboxylate, and --OR 3 wherein --R 3 is unsubstituted alkyl having from about 1 to about 3 carbon atoms; and wherein any aryl substituent is selected from the group consisting of halogen, hydroxy, C 1 -C 16 alkoxy, amino, nitro, cyano, phenyl, benzyl, benzyloxy, trifluoromethyl, formylamino, carboxylate and C 1 -C 6 alkyl.
Claim 16
Dependent Claim 269 words
Beta-aminoethyl-substituted phenyl compounds which are effective as anti-inflammatory or analgesic agents, and the pharmaceutically-acceptable salts and amides thereof, having the general structure: ##STR47## wherein: (a) ═Q is selected from the group consisting of oxygen or sulfur; (b) --Y-- is a moiety selected from the group consisting of --O--, --S-- and --NR 4 --, where --R 4 is selected from hydrogen and C 1 -C 4 alkanyl; (c) --Z is selected from the group consisting of hydrogen, hydroxy, and methoxy; (d) --R is an alkyl group having from about 1 to about 24 carbon atoms; (e) --R 1 is selected from the group consisting of hydrogen, hydroxy, alkyl esters of hydroxy having from about 1 to about 5 carbon atoms, alkyl having from about 1 to about 5 carbon atoms, and alkoxy having from about 1 to about 5 carbon atoms; and (f) each --R 2 is independently selected from hydrogen, halogen, unsubstituted or substituted alkyl having from about 1 to about 6 carbon atoms, substituted or unsubstituted aryl, and carboxylate, or two --R 2 moieties are covalently bonded to form a substituted or unsubstituted alkyl or aryl ring having from about 3 to about 8 carbon atoms in the ring; wherein any alkyl ring substituent is selected from the group consisting of halogen, hydroxy, amino, aryl, carboxylate, and --OR 3 wherein --R 3 is unsubstituted alkyl having from about 1 to about 3 carbon atoms; and wherein any aryl substituent is selected from the group consisting of halogen, hydroxy, C 1 -C 16 alkoxy, amino, nitro, cyano, phenyl, benzyl, benzyloxy, trifluoromethyl, formylamino, carboxylate and C 1 -C 6 alkyl.
Claim 17
Dependent Claim 32 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 13, wherein --Y-- is --O--, and --R 1 is selected from the group consisting of hydrogen, hydroxy and methyl.
Claim 18
Dependent Claim 18 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 14, wherein ═Q is oxygen.
Claim 19
Dependent Claim 126 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 15, wherein --R 1 is hydrogen; both --R 2 on the alpha carbon atom are hydrogen; both --R 2 on the beta carbon atom are selected from hydrogen and alkyl having from 1 to about 5 carbon atoms or the --R 2 are covalently bonded to form an alkyl ring having from about 3 to about 6 carbon atoms, the alkyl or alkyl ring being unsubstituted or substituted with phenyl; and --R is selected from the group consisting of alkanyl groups having from about 6 to about 14 carbon atoms, alkenyl groups having from about 14 to about 22 carbon atoms, and alkynyl groups having from about 14 to about 22 carbon atoms.
Claim 20
Dependent Claim 58 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 16, wherein --Z is methoxy; and --R is selected from the group consisting of n-hexanyl, n-heptanyl, n-octanyl, n-nonanyl, n-decanyl, n-undecanyl, n-dodecanyl, n-tridecanyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, nonadecenyl, eicosenyl, docosenyl, heptadecadienyl, octadecadienyl, nonadecadienyl, eicosadienyl, heptadecatrienyl, octadecatrienyl, nonadecatrienyl, eicosatrienyl, nonadecatetraenyl, heptadecynyl, octadecynyl, nonadecynyl, and eicosynyl.
Claim 21
Dependent Claim 27 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 17, selected from the group consisting of N-((4-(2-aminoethoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide; N-((4-(2-aminoethoxy)-3-methoxyphenyl)-methyl)-nonanamide; N-((4-(2-methyl-2-aminopropoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide; N-((4-(2(S)-amino-3-methylbutoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide; N-((4-(2-amino-3-hydroxypropoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide; and N-((4-(2-amino-2-carboxyethoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide
Claim 22
Dependent Claim 110 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 17, wherein both --R 2 on the beta carbon atom are selected from the group consisting of hydrogen, methyl, ethyl, and both --R 2 being covalently bonded to form a C 3 -C 5 saturated alkyl ring; and --R is selected from the group consisting of n-heptanyl; n-octanyl; n-nonanyl; 8E- or 8Z-tridecenyl; BE- or 8Z-pentadecenyl; 8E- or 8Z-heptadecenyl; 5E- or 5Z-heptadecenyl; 10E- or 10Z-heptadecenyl; 9E- or 9Z-octadecenyl; 12E- or 12Z-nonadecenyl; 8-methylene-1-heptadecanyl; 8Z, 11Z-heptadecadienyl; 8E, 11E-heptadecadienyl; 8Z, 11E-heptadecadienyl; 8Z, 10E-heptadecadienyl; 9E, 12E-octadecadienyl; 10E,13E-nonadecadienyl; 8Z, 11Z, 14Z-heptadecatrienyl; 5Z, 8Z, 11Z-heptadecatrienyl; 10Z, 13Z, 16Z-nonadecatrienyl; 4Z, 7Z, 10Z, 13Z-nonadecatetraenyl; and 8-heptadecynyl.
Claim 23
Dependent Claim 25 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 19, selected from the group consisting of N-((4-(2-aminoethoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide, N-((4(2-aminoethoxy)-3-methoxyphenyl)-methyl)-nonanamide, N-((4-(2-methyl-2-aminopropoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide, and N-((4-(2-methyl-2-aminopropoxy)-3-methoxyphenyl)-methyl)nonanamide.
Claim 24
Dependent Claim 36 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 16, wherein both --R 2 on the alpha carbon atoms are hydrogen and both --R 2 on the beta carbon atom are methyl.
Claim 25
Dependent Claim 20 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 16, where all --R 2 are hydrogen.
Claim 26
Dependent Claim 19 words
Beta-aminoethyl-substituted phenyl compounds, and the pharmaceutically-acceptable salts and amides thereof, according to claim 19, wherein the compound is N-((4-(2-aminoethoxy)-3-methoxyphenyl)-methyl)-9Z-octadecenamide.
Claim 27
Dependent Claim 31 words
Pharmaceutical compositions comprising: (a) a safe and effective amount of a compound according to any of claim 1, 3, 4, 7, 9, 13, 16, or 19; and (b) a pharmaceutically-acceptable carrier.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-09-02 1995-03-04 1995-09-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-09-02 1999-03-04 1999-09-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-09-02 2003-03-04 2003-09-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag